These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2456140)

  • 1. Review of antiplatelet drug use in preventing restenosis following percutaneous transluminal coronary angioplasty.
    Cox JL; Gotlieb AI
    Can J Cardiol; 1988 May; 4(4):201-10. PubMed ID: 2456140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the methodology of percutaneous transluminal coronary angioplasty on restenosis.
    Douglas JS; King SB; Roubin GS
    Am J Cardiol; 1987 Jul; 60(3):29B-33B. PubMed ID: 2956837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?
    Steinhubl S; Berger P
    Am Heart J; 2003 Jun; 145(6):971-8. PubMed ID: 12796751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preventive drug therapy following coronary bypass surgery or PTCA].
    Lechleitner P; Genser N; Dienstl F
    Wien Med Wochenschr; 1990 Jun; 140(10-11):277-8, 281. PubMed ID: 2368420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention].
    Böger RH; Bode-Böger SM; Alfke H
    Vasa; 1996; 25(1):21-31. PubMed ID: 8851262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Restenosis after coronary angioplasty: its pathogenesis and prevention].
    Marzocchi A; Marrozzini C; Piovaccari G; Fattori R; Castriota F; D'Anniballe G; Branzi A; Magnani B
    Cardiologia; 1991 Dec; 36(12 Suppl 1):309-20. PubMed ID: 1841786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry.
    Eisenberg MJ; Okrainec K; Lefkovits J; Goudreau E; Deligonul U; Mak KH; Duerr R; Tsang J; Huynh T; Sedlis S; Brown DL; Brieger D; Pilote L;
    Can J Cardiol; 2003 Aug; 19(9):1009-15. PubMed ID: 12915928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients.
    Ziegler S; Maca T; Alt E; Speiser W; Schneider B; Minar E
    Platelets; 2002 Dec; 13(8):493-7. PubMed ID: 12487783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ticlopidine and aspirin therapy following implantation of coronary artery stents.
    Hobson AG; Sowinski KM
    Ann Pharmacother; 1997 Jun; 31(6):770-2. PubMed ID: 9184720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel antagonists reduce restenosis after percutaneous transluminal angioplasty of an arteriovenous fistula in hemodialysis patients.
    Doi S; Masaki T; Shigemoto K; Harada S; Yorioka N
    Ther Apher Dial; 2008 Jun; 12(3):232-6. PubMed ID: 18503701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Restenosis after percutaneous transluminal coronary angioplasty and its prevention].
    Przewłocka-Kosmala M; Kosmala W
    Przegl Lek; 1999; 56(10):671-5. PubMed ID: 10695384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features.
    Cox JL; Gotlieb AI
    CMAJ; 1986 May; 134(10):1129-32. PubMed ID: 2938706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrent stenosis following coronary angioplasty. Clinical, cell biological and molecular aspects].
    Hombach V; Waltenberger J; Voisard R; Höher M
    Z Kardiol; 1995 Jan; 84(1):5-21. PubMed ID: 7863714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current antiplatelet therapies: benefits and limitations.
    Angiolillo DJ; Guzman LA; Bass TA
    Am Heart J; 2008 Aug; 156(2 Suppl):S3-9. PubMed ID: 18657680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restenosis following coronary angioplasty.
    Karas SP; Santoian EC; Gravanis MB
    Clin Cardiol; 1991 Oct; 14(10):791-801. PubMed ID: 1954687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-vessel wall interactions in the development of restenosis after coronary angioplasty.
    Monsen CH; Adams PC; Badimon L; Chesebro JH; Fuster V
    Z Kardiol; 1987; 76 Suppl 6():23-8. PubMed ID: 2964144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiplatelet therapy during coronary endoprosthesis placement].
    Barragan P; Pietri P; Villain P; Silvestri M; Roquebert PO
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1515-20. PubMed ID: 9092412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Frankfurt experience in restenosis after coronary angioplasty.
    Bussmann WD; Kaltenbach M; Kober G; Vallbracht C
    Am J Cardiol; 1987 Jul; 60(3):48B-49B. PubMed ID: 2956842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathophysiology of restenosis following percutaneous transluminal coronary angioplasty].
    Holm AM; Haunsø S; Hansen PR
    Ugeskr Laeger; 1998 Feb; 160(9):1302-6. PubMed ID: 9495077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.